CESSA logo

Cessatech A/S Stock Price

NGM:CESSA Community·DKK 339.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

CESSA Share Price Performance

DKK 18.25
3.53 (23.98%)
DKK 18.25
3.53 (23.98%)
Price DKK 18.25

CESSA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

Cessatech A/S Key Details

DKK 4.5m

Revenue

DKK 0

Cost of Revenue

DKK 4.5m

Gross Profit

DKK 14.3m

Other Expenses

-DKK 9.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.53
100.00%
-219.80%
0%
View Full Analysis

About CESSA

Founded
2020
Employees
3
CEO
Jes Trygved
WebsiteView website
www.cessatech.com

Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development. Cessatech A/S was incorporated in 2020 and is based in Copenhagen, Denmark.

Recent CESSA News & Updates

Recent updates

No updates